{"id":"https://openalex.org/W4393093006","doi":"https://doi.org/10.1158/1538-7445.am2024-2099","title":"Abstract 2099: PELP1 inhibition enhances the therapeutic efficacy of topoisomerase inhibitors in triple-negative breast cancer","display_name":"Abstract 2099: PELP1 inhibition enhances the therapeutic efficacy of topoisomerase inhibitors in triple-negative breast cancer","publication_year":2024,"publication_date":"2024-03-22","ids":{"openalex":"https://openalex.org/W4393093006","doi":"https://doi.org/10.1158/1538-7445.am2024-2099"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2024-2099","doi":"https://doi.org/10.1158/1538-7445.am2024-2099","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2024-2099","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Khaled Mohamed Nassar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Khaled Mohamed Nassar","raw_affiliation_strings":["1UT Health San Antonio, San Antonio, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT Health San Antonio, San Antonio, TX","institution_ids":["https://openalex.org/I165951966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022585394","display_name":"John R. Sanchez","orcid":"https://orcid.org/0000-0002-5362-1025","observed_orcids":["https://orcid.org/0000-0002-5362-1025"]},"institutions":[{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John R. Sanchez","raw_affiliation_strings":["1UT Health San Antonio, San Antonio, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT Health San Antonio, San Antonio, TX","institution_ids":["https://openalex.org/I165951966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020865378","display_name":"Durga Meenakshi Panneerdoss","orcid":"https://orcid.org/0009-0001-8162-5277","observed_orcids":["https://orcid.org/0009-0001-8162-5277"]},"institutions":[{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Durga Meenakshi Panneerdoss","raw_affiliation_strings":["1UT Health San Antonio, San Antonio, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT Health San Antonio, San Antonio, TX","institution_ids":["https://openalex.org/I165951966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079514337","display_name":"Behnam Ebrahimi","orcid":"https://orcid.org/0000-0003-4588-7525","observed_orcids":["https://orcid.org/0000-0003-4588-7525"]},"institutions":[{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Behnam Ebrahimi","raw_affiliation_strings":["1UT Health San Antonio, San Antonio, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT Health San Antonio, San Antonio, TX","institution_ids":["https://openalex.org/I165951966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100399514","display_name":"Xue Na Yang","orcid":"https://orcid.org/0000-0002-6595-6498","observed_orcids":["https://orcid.org/0000-0002-6595-6498"]},"institutions":[{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yang Xue","raw_affiliation_strings":["1UT Health San Antonio, San Antonio, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT Health San Antonio, San Antonio, TX","institution_ids":["https://openalex.org/I165951966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064393266","display_name":"Uday P. Pratap","orcid":"https://orcid.org/0000-0003-2973-0210","observed_orcids":["https://orcid.org/0000-0003-2973-0210"]},"institutions":[{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Uday P. Pratap","raw_affiliation_strings":["1UT Health San Antonio, San Antonio, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT Health San Antonio, San Antonio, TX","institution_ids":["https://openalex.org/I165951966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047718399","display_name":"Salvador Alejo","orcid":"https://orcid.org/0000-0002-1390-9892","observed_orcids":["https://orcid.org/0000-0002-1390-9892"]},"institutions":[{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Salvador C. Alejo","raw_affiliation_strings":["1UT Health San Antonio, San Antonio, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT Health San Antonio, San Antonio, TX","institution_ids":["https://openalex.org/I165951966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060877175","display_name":"Gangadhara R. Sareddy","orcid":"https://orcid.org/0000-0001-9977-3932","observed_orcids":["https://orcid.org/0000-0001-9977-3932"]},"institutions":[{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gangadhara R. Sareddy","raw_affiliation_strings":["1UT Health San Antonio, San Antonio, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT Health San Antonio, San Antonio, TX","institution_ids":["https://openalex.org/I165951966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043867874","display_name":"Suryavathi Viswanadhapalli","orcid":"https://orcid.org/0000-0002-7381-6962","observed_orcids":["https://orcid.org/0000-0002-7381-6962"]},"institutions":[{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Suryavathi Viswanadhapalli","raw_affiliation_strings":["1UT Health San Antonio, San Antonio, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT Health San Antonio, San Antonio, TX","institution_ids":["https://openalex.org/I165951966"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5090010000","display_name":"Ratna K. Vadlamudi","orcid":"https://orcid.org/0000-0003-2849-4076","observed_orcids":["https://orcid.org/0000-0003-2849-4076"]},"institutions":[{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ratna K. Vadlamudi","raw_affiliation_strings":["1UT Health San Antonio, San Antonio, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT Health San Antonio, San Antonio, TX","institution_ids":["https://openalex.org/I165951966"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I165951966"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"84","issue":"6_Supplement","first_page":"2099","last_page":"2099"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.5903000235557556,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.5903000235557556,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.3456999957561493,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.007300000172108412,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pelp1","display_name":"PELP1","score":0.8709999918937683},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.9309999942779541},{"id":"https://openalex.org/keywords/topoisomerase-inhibitors","display_name":"topoisomerase inhibitors","score":0.996999979019165},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.8790000081062317},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.675000011920929},{"id":"https://openalex.org/keywords/dna-damage-response","display_name":"DNA damage response","score":0.8809999823570251},{"id":"https://openalex.org/keywords/gamma-h2ax","display_name":"\u03b3H2AX","score":0.8870000243186951},{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":0.8899999856948853},{"id":"https://openalex.org/keywords/valrubicin","display_name":"valrubicin","score":0.9950000047683716},{"id":"https://openalex.org/keywords/mitoxantrone","display_name":"mitoxantrone","score":0.996999979019165},{"id":"https://openalex.org/keywords/patient-derived-organoids","display_name":"patient-derived organoids","score":0.7670000195503235},{"id":"https://openalex.org/keywords/xenografts","display_name":"xenografts","score":0.7699999809265137},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.5199999809265137},{"id":"https://openalex.org/keywords/oncogene-inhibition","display_name":"oncogene inhibition","score":0.47999998927116394},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.574999988079071}],"concepts":[{"id":"https://openalex.org/C147897179","wikidata":"https://www.wikidata.org/wiki/Q407828","display_name":"Topoisomerase","level":3,"score":0.787615180015564},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6588857769966125},{"id":"https://openalex.org/C2780110267","wikidata":"https://www.wikidata.org/wiki/Q7843332","display_name":"Triple-negative breast cancer","level":4,"score":0.6360926628112793},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5915396213531494},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5670436024665833},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4367966055870056},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4046799838542938},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3991044759750366},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3188042640686035},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2118496298789978},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.14035820960998535},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.04629036784172058}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2024-2099","doi":"https://doi.org/10.1158/1538-7445.am2024-2099","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2024-2099","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4409639542","https://openalex.org/W7129673200","https://openalex.org/W3180019320","https://openalex.org/W4377010624","https://openalex.org/W3079150579","https://openalex.org/W3013130861","https://openalex.org/W2023958693","https://openalex.org/W2093976463","https://openalex.org/W2570352383","https://openalex.org/W3165290637"],"abstract_inverted_index":{"Abstract":[0],"BACKGROUND:":[1],"Triple":[2],"negative":[3],"breast":[4,11,450],"cancers":[5],"(TNBCs)":[6],"account":[7],"for":[8,98,394,459],"15-24%":[9],"of":[10,54,63,76,84,86,108,121,128,167,188,238,244,274,286,333,365,397,402,445,455],"cancer":[12,451],"deaths":[13],"and":[14,24,33,47,69,93,141,160,178,217,229,252,267,325,328,351,368,372,405],"are":[15],"characterized":[16],"by":[17,222,307,320],"aggressive":[18],"clinical":[19],"course,":[20],"a":[21,25,51,59,99,225,390],"worse":[22],"prognosis,":[23],"higher":[26,284],"propensity":[27],"to":[28,68,80,94,203,240,294,380],"metastasize.":[29],"Proline,":[30],"glutamic":[31],"acid-,":[32],"leucine-rich":[34],"protein":[35,226],"1":[36,466],"(PELP1)":[37],"is":[38,43,50,79,346],"an":[39,184],"oncogene,":[40],"its":[41,48],"expression":[42,345],"deregulated":[44],"in":[45,90,112,185,192,259,276,288,353,370,377,448],"TNBC,":[46,398],"status":[49],"prognostic":[52],"indicator":[53],"poor":[55],"TNBC":[56,91,123,201,249,366],"survival.":[57],"Recently,":[58],"small":[60],"molecule":[61],"inhibitor":[62,88,408],"PELP1":[64,71,87,109,275,344,407,439],"(SMIP34)":[65],"which":[66],"binds":[67],"degrades":[70],"was":[72,135,170],"developed.":[73],"The":[74,126],"Objective":[75],"this":[77],"proposal":[78],"define":[81],"the":[82,96,106,164,209,212,236,242,272,298,308,363,395,400,406,442,456],"mechanism":[83],"action":[85],"SMIP34":[89,129,199,239,355],"progression":[92],"pave":[95],"path":[97],"novel":[100,391],"combination":[101,113,130,168,193,290,312,359,401],"therapy.":[102,313],"METHODS:":[103],"We":[104,182,234],"tested":[105],"effectiveness":[107],"inhibitor,":[110],"SMIP-34,":[111],"with":[114,194,271,349],"140":[115,189],"FDA-approved":[116,190],"medications":[117],"on":[118,132],"cell":[119,124,133,250,263],"survival":[120,134],"multiple":[122],"lines.":[125],"effect":[127],"therapy":[131,169,291,393],"measured":[136],"using":[137,150,172,246,257,316,339],"MTT,":[138],"colony":[139,265],"formation,":[140,266],"Annexin":[142],"V":[143],"apoptosis":[144],"assays.":[145,162],"Mechanistic":[146,314],"studies":[147,315],"were":[148],"done":[149],"RT-qPCR,":[151],"immunoprecipitation,":[152],"proximity":[153],"ligation,":[154],"mass":[155],"spectrometry,":[156],"gene":[157,336],"reporter,":[158],"immunofluorescence,":[159],"comet":[161,299],"Furthermore,":[163,335],"preclinical":[165],"utility":[166],"evaluated":[171],"MDA-MB-231":[173,373],"xenografts,":[174],"patient-derived":[175],"organoids":[176],"(PDOs)":[177],"explants":[179],"(PDEs).":[180],"RESULTS:":[181],"performed":[183],"vitro":[186,260],"screening":[187],"drugs":[191,214],"SMIP34.":[195,409],"Results":[196,296],"revealed":[197,342],"that":[198,227,343],"sensitized":[200],"cells":[202],"five":[204,210],"FDA":[205],"approved":[206],"drugs.":[207],"Of":[208],"drugs,":[211],"three":[213],"Gemcitabine,":[215],"Valrubicin,":[216],"Mitoxantrone,":[218],"induced":[219],"DNA":[220,231,277,304],"damage":[221,278,305],"inhibiting":[223],"topoisomerase,":[224],"cleaves":[228],"reconnects":[230],"during":[232],"replication.":[233],"validated":[235],"ability":[237],"enhance":[241],"efficacy":[243,444],"TIs":[245,311],"two":[247],"additional":[248],"lines":[251],"confirmed":[253],"their":[254],"synergistic":[255],"activity":[256],"several":[258],"assays":[261,300],"including":[262],"viability,":[264],"apoptosis.":[268],"In":[269],"agreement":[270],"role":[273],"response,":[279],"Western":[280],"blotting":[281],"analyses":[282],"showed":[283],"levels":[285],"\u03b3-H2AX":[287],"SMIP34+TI":[289],"when":[292],"compared":[293,379],"monotherapy.":[295],"from":[297],"further":[301],"demonstrate":[302],"increased":[303],"caused":[306],"SMIP-34":[309],"+":[310],"Proximity":[317],"labelling":[318],"followed":[319],"immunoprecipitation":[321],"identified":[322],"topoisomerase":[323,403,446],"2A":[324],"2B":[326],"(TOP2A":[327],"TOP2B)":[329],"as":[330],"potential":[331],"interactors":[332],"PELP1.":[334],"correlation":[337],"analysis":[338],"TCGA":[340],"datasets":[341],"positively":[347],"correlated":[348],"TOP2A,":[350],"TOP2B":[352],"TNBC.":[354],"plus":[356],"Mitoxantrone":[357],"(TI)":[358],"treatment":[360,396],"significantly":[361],"reduced":[362],"growth":[364,376],"PDEXs,":[367],"PDOs":[369],"vitro,":[371],"xenograft":[374],"tumor":[375],"vivo,":[378],"vehicle":[381],"or":[382],"monotherapy":[383],"treatment.":[384],"CONCLUSION:":[385],"Together,":[386],"these":[387],"results":[388],"suggest":[389],"targeted":[392],"involving":[399],"inhibitors":[404,447],"Citation":[410],"Format:":[411],"Khaled":[412],"Mohamed":[413],"Nassar,":[414],"John":[415],"R.":[416,432],"Sanchez,":[417],"Durga":[418],"Meenakshi":[419],"Panneerdoss,":[420],"Behnam":[421],"Ebrahimi,":[422],"Yang":[423],"Xue,":[424],"Uday":[425],"P.":[426],"Pratap,":[427],"Salvador":[428],"C.":[429],"Alejo,":[430],"Gangadhara":[431],"Sareddy,":[433],"Suryavathi":[434],"Viswanadhapalli,":[435],"Ratna":[436],"K.":[437],"Vadlamudi.":[438],"inhibition":[440],"enhances":[441],"therapeutic":[443],"triple-negative":[449],"[abstract].":[452],"In:":[453],"Proceedings":[454],"American":[457],"Association":[458],"Cancer":[460,478],"Research":[461],"Annual":[462],"Meeting":[463],"2024;":[464],"Part":[465],"(Regular":[467],"Abstracts);":[468],"2024":[469],"Apr":[470],"5-10;":[471],"San":[472],"Diego,":[473],"CA.":[474],"Philadelphia":[475],"(PA):":[476],"AACR;":[477],"Res":[479],"2024;84(6_Suppl):Abstract":[480],"nr":[481],"2099.":[482]},"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-10-13T10:08:12.033832","created_date":"2024-03-23T00:00:00"}